https://www.selleckchem.com/products/sd49-7.html
Introduction Atrial fibrillation (AF) is associated with an increased risk of stroke. Stroke prevention with oral anticoagulation (OAC) is recommended in AF patients at increased risk of stroke. The left atrial appendage (LAA) is the main source of thrombus formation in AF patients. The WATCHMAN percutaneous LAA closure (LAAC) device may serve as an alternative to OAC overcoming disadvantages including the risk of (major) bleeding. Areas covered This review will focus on LAAC with the Watchman device for stroke prevention in AF patients.
Gefällt mir
Kommentar
Teilen
